QooQoo Retained by Perimeter Medical Imaging AI to Drive Adoption of Innovative Tissue Margin Visualization Technology

QooQoo, a growing healthcare marketing agency in Southern California, announced that it has been retained by Perimeter Medical Imaging AI, a medical technology company with headquarters in Toronto, ON, and Dallas, TX.

Using their Business Before Brand methodology, QooQoo will create an omni-channel adoption and awareness campaign for Perimeter Medical’s innovative S-Series OCT (Optical Coherence Tomography) device, a pioneering high-resolution intraoperative imaging technology.

Clay Daniells, QooQoo founder and CEO, says partnering with Perimeter Medical is an exciting opportunity to impact clinicians across multiple specialties. “With real-time margin visualization inside the operating room, surgical oncologists can better evaluate whether or not they have excised all of the tissue associated with residual disease, in that moment. This technology is a game changer for surgeons concerned with taking excess tissue or the various risks surrounding re-excision.”

“We are excited to partner with QooQoo as we articulate our unique value proposition and accelerate our commercial momentum, placing Perimeter’s S-Series OCT medical imaging system in hospitals across the U.S.,” says Linda Thomas, Marketing Director at Perimeter Medical. “We’re confident their unique strategic and creative capabilities, combined with their medical device knowledge, will serve us well.”

SourceQooQoo

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.